The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.
Showing results 1 - 6 of 93
Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women
Researchers from the HIV Prevention Trials Network presented updated results from the HPTN 084 cabotegravir for PrEP study in cisgender women at the AIDS 2022 conference in Montreal. This press release provides an overview of the new findings presented which show reductions in HIV incidence were sustained in the 12 months following trial unblinding.
Breaking the Cycle of Transmission Strategy Toolkit
This toolkit, comprising four strategic tools, has been developed to help programs working with Adolescent Girls and Young Women (AGYW) to design successful interventions for HIV Prevention.
Dual Prevention Pill Desk Review Insights
This desk review by M&C Saatchi collates existing data and insights related to uptake and adherence to HIV prevention, contraceptive, and multi-purpose technology pill products; confirms and identifies gaps in the existing knowledge base; and prompts discussions around key learning questions that need to be addressed to develop a robust and effective marketing and demand…
Review of Effective Marketing and Demand Creation Strategies in HIV Prevention and Family Planning that May Inform Demand-Side Thinking for the Dual Prevention Pill
This scoping review aims to document effective and sustainable demand creation strategies used in HIV prevention and Family Planning interventions, how they may be adapted for the Dual Prevention Pill (DPP), and explores what could be done differently for the DPP.
Zimbabwe PrEP Ring Stakeholder Consultations Summary
This country-level analysis from Zimbabwe shares key stakeholder perceptions of the ring and is the product of consultations led by WHO, IPM, and MOSAIC during the period December 2021 – March 2022.